Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
CleanSpark's Bitcoin Reserves Surpass $1 Billion in Value, Q3 Revenue Soars 91% Year-on-Year

CleanSpark's Bitcoin Reserves Surpass $1 Billion in Value, Q3 Revenue Soars 91% Year-on-Year

金色财经金色财经2025/08/07 22:38
Show original

According to Jinse Finance, Bitcoin mining company CleanSpark (NASDAQ: CLSK) has released its financial results for the third quarter of fiscal year 2025, reporting a 91% year-over-year increase in revenue to $198.6 million and a net profit of $257.4 million. Net profit may exceed revenue due to non-operating income, such as gains from asset sales, investments, or one-off events, which are included in net profit but not in revenue. Benefiting from the rise in Bitcoin prices (which increased from around $86,500 to approximately $109,000 during Q3) and an expanded Bitcoin holding, the total value of CleanSpark’s Bitcoin reserves is about $1.08 billion, making up a significant portion of the company’s total assets of $3.1 billion. CleanSpark also announced that its computing power has reached 50 EH/s, accounting for 5.8% of global hash rate, making it the first publicly listed company to achieve this level solely through U.S.-based infrastructure.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage